PYC Therapeutics
Rohan Hockings holds double degrees in medicine and law. He has worked across both disciplines following an internship at Sir Charles Gairdner Hospital and admission to practice in the Supreme Court of Victoria respectively.
He spent four years with McKinsey & Company and a further two years in the Private Equity industry before joining PYC Therapeutics. Rohan brings a deep affinity for conceptual thinking to PYC Therapeutics along with an understanding of the company’s technology and its commercialisation path.
This person is not in any offices
PYC Therapeutics
1 followers
PYC Therapeutics is a development-stage biotechnology company pioneering a new generation of RNA therapeutics that utilize Cell Penetrating Peptides (CPPs), a revolutionary delivery technology designed to overcome the major challenges of current gene-based therapies.